Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12186324
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 12186330
Compositions for improving cell viability and methods of use thereof
granted -
US 12186282
Treatment of 22Q11.2 deletion syndrome with cannabidiol
granted -
US 12186314
Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia
granted -
US 12188039
Recombinant adeno-associated viral vector for gene delivery
granted -
US 12187779
Anti-human papillomavirus 16 E6 T cell receptors
granted -
US 12187746
C26-linked rapamycin analogs as mTOR inhibitors
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12186375
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
granted -
US 12187772
IL10 agonists and methods of use thereof
granted -
US 12186368
Compositions and methods for treatment of protease mediated disease
granted -
US 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted -
US 12186306
Methods of treatment for cystic fibrosis
granted -
US 12188020
Methods for reducing Ataxin-2 expression
granted -
US 12186313
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 12186363
Compositions and methods for dengue virus chimeric constructions in vaccines
granted -
US 12187731
Compounds useful as inhibitors of ATR kinase
granted -
US 12186384
Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
granted -
US 12187777
Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof
granted -
US 12187780
Car t-cells comprising inactivated CBL and CBL-B genes
granted -
US 12187698
Crystalline forms of C21H22Cl2N4O2
granted -
US 12187694
SLC26A3 inhibitors and use thereof
granted -
US 12187679
Hydroxylated psilocybin derivatives and methods of using
granted -
US 12186428
Combination taxoid nanoemulsion with immunotherapy in cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.